Product information and disease descriptionProduct descriptionProduct information
Generic, brand name and therapeutic class of product
4 evidence topics · 10 sources
Generic name, chemical name, and identifiers
| Field | Quoted record |
|---|---|
| International nonproprietary name (Latin) | “inaxaplinum” |
| International nonproprietary name (English) | “inaxaplin” |
| Chemical name | “3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-N- [(3S,4R)-4-hydroxy-2-oxopyrrolidin-3-yl]propanamide” |
| Functional description | “apolipoprotein L1 (APOL1) function inhibitor” |
| Molecular formula | “C21H18F3N3O3” |
| CAS registry number | “2446816-88-0” |
| INN list | “Proposed INN: List 125” |
Development codes: VX-147 and IXP
Brand name
No evidence found.
Manufacturer: Vertex Pharmaceuticals
| Field | Quoted record |
|---|---|
| Sponsor | “Vertex Pharmaceuticals Inc.” |
| Marketing authorisation holder of the investigational product | “VERTEX PHARMACEUTICALS, INCORPORATED” |